New hope for transplant patients: can a common pill sharpen blood sugar control?
NCT ID NCT07228195
Summary
This study is testing if adding the diabetes drug empagliflozin helps people who have had a specific pancreas surgery (TPIAT) better control their blood sugar levels. It will involve 40 adults who still produce some of their own insulin after the transplant. Researchers will compare three groups: one taking no extra drug, one taking a low dose, and one taking a higher dose, to see which best improves time spent in a healthy blood sugar range.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.